tiprankstipranks
Valeo Pharma Inc (VPHIF)
:VPHIF
US Market

Valeo Pharma (VPHIF) Financial Statements

Compare
14 Followers

Valeo Pharma Financial Overview

Valeo Pharma's market cap is currently $3.10M. The company's EPS TTM is $-0.25; its P/E ratio is ―; Valeo Pharma is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueC$ 53.91MC$ 27.75MC$ 13.56MC$ 7.47MC$ 6.58M
Gross ProfitC$ 13.08MC$ 6.28MC$ 3.96MC$ 1.38MC$ 1.40M
Operating IncomeC$ -17.23MC$ -19.60MC$ -12.94MC$ -4.12MC$ -3.54M
EBITDAC$ -11.39MC$ -17.56MC$ -11.86MC$ -3.74MC$ -3.41M
Net IncomeC$ -27.81MC$ -25.75MC$ -14.23MC$ -4.76MC$ -3.62M
Balance Sheet
Cash & Short-Term InvestmentsC$ 7.50MC$ 22.50MC$ 2.04MC$ 2.84MC$ 335.00K
Total AssetsC$ 41.21MC$ 58.27MC$ 21.03MC$ 10.96MC$ 5.81M
Total DebtC$ 65.17MC$ 61.44MC$ 7.67MC$ 3.26MC$ 1.00M
Net DebtC$ 57.67MC$ 38.94MC$ 5.63MC$ 426.00KC$ 666.00K
Total LiabilitiesC$ 81.54MC$ 76.11MC$ 18.98MC$ 7.89MC$ 5.83M
Stockholders' EquityC$ -40.34MC$ -17.85MC$ 2.05MC$ 3.07MC$ -22.00K
Cash Flow
Free Cash FlowC$ -21.25MC$ -35.39MC$ -15.78MC$ -6.70MC$ -3.25M
Operating Cash FlowC$ -15.70MC$ -28.50MC$ -12.31MC$ -5.30MC$ -2.31M
Investing Cash FlowC$ -5.55MC$ -6.89MC$ -3.46MC$ -1.41MC$ -923.00K
Financing Cash FlowC$ 6.19MC$ 54.99MC$ 15.10MC$ 9.21MC$ 3.55M
Currency in CAD

Valeo Pharma Earnings and Revenue History

Valeo Pharma Debt to Assets

Valeo Pharma Cash Flow

Valeo Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis